Liolis Gateway September 2018 Presentation

This presentation contains forward-looking statements that involve risks and uncertainties, including but not limited to those related to the growth of the home infusion market, our SG&A expenditures and the potential for Nasdaq uplisting. Actual results and events may differ significantly from results and events discussed in the forward-looking statements. Factors that might cause or … Continued

Appointment of Executive Officer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549   FORM 8-K   CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported)   September 4, 2018   REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter)   New … Continued

RMS to Present at the 8th Annual LD Micro Invitational Conference

Chester, NY / May 23, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that Lead Independent Director Dan Goldberger will be presenting at the 8th annual LD Micro Invitational Conference taking place June 4-6, 2018 at the Luxe Sunset hotel in Bel-Air, California.   The Company’s presentation will take … Continued

Daniel Goldberger Nominated for Election to RMS Board of Directors

CHESTER, NY / March 14, 2018 / The Board of Directors of Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced that seasoned senior executive and business leader Daniel Goldberger has been nominated to stand for election to the board at the Company’s Annual Meeting of Shareholders on April 23, 2018, replacing … Continued

RMS Proxy Statement 14(a) March 2018

Notice of Annual Meeting of Shareholders To Be Held April 23, 2018 The 2018 Annual Meeting of Shareholders (the “Annual Meeting”) of Repro Med Systems, Inc. (the “Company”) will be held on April 23, 2018 at 3:00 p.m. Eastern Standard Time at the Company’s Corporate Offices located at 24 Carpenter Road, Chester, New York, 10918, … Continued

RMS Announces Results for Three, Ten and Twelve Months Ending December 31, 2017

Highest reported twelve month net sales and net income in RMS history Double digit percentage growth in net sales Increased profitability CHESTER, NY / February 13, 2018 / Repro Med Systems, Inc. dba RMS Medical Products (OTCQX: REPR) today announced the latest financial results for the three, ten and twelve months ending December 31, 2017. … Continued

RMS Announces Departure of Executive Officer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934